These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11267976)
1. Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines. Pellizzaro C; Coradini D; Daniotti A; Abolafio G; Daidone MG Int J Cancer; 2001 Mar; 91(5):654-7. PubMed ID: 11267976 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783 [TBL] [Abstract][Full Text] [Related]
3. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells. Schmidt M; Fan Z Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424 [TBL] [Abstract][Full Text] [Related]
4. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression. Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587 [TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
6. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340 [TBL] [Abstract][Full Text] [Related]
8. Effects of sodium butyrate on expression of members of the IGF-binding protein superfamily in human mammary epithelial cells. Tsubaki J; Choi WK; Ingermann AR; Twigg SM; Kim HS; Rosenfeld RG; Oh Y J Endocrinol; 2001 Apr; 169(1):97-110. PubMed ID: 11250651 [TBL] [Abstract][Full Text] [Related]
9. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma. Izban KF; Alkan S; Singleton TP; Hsi ED Arch Pathol Lab Med; 2000 Oct; 124(10):1457-62. PubMed ID: 11035575 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Marra DE; Simoncini T; Liao JK Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431 [TBL] [Abstract][Full Text] [Related]
11. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888 [TBL] [Abstract][Full Text] [Related]
13. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells. Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511 [TBL] [Abstract][Full Text] [Related]
14. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53. Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613 [TBL] [Abstract][Full Text] [Related]
15. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer. Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. Wong SC; Chan JK; Lee KC; Hsiao WL J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139 [TBL] [Abstract][Full Text] [Related]
17. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Saegusa M; Machida B D; Okayasu I Cancer; 2001 Sep; 92(5):1177-89. PubMed ID: 11571731 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition. Shambaugh GE; Haines GK; Koch A; Lee EJ; Zhou Jn; Pestell R Brain Res; 2000 Feb; 855(1):11-22. PubMed ID: 10650125 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related]